Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
Zhou Y, Huang Z, Su J, Li J, Zhao S, Wu L, Zhang J, He Y, Zhang G, Tao J, Zhou J, Chen X, Peng C.
Zhou Y, et al. Among authors: zhao s.
Int J Cancer. 2020 Jul 1;147(1):139-151. doi: 10.1002/ijc.32756. Epub 2019 Nov 13.
Int J Cancer. 2020.
PMID: 31652354